The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $15 million Indefinite Delivery Contract (IDC) to Rutgers, The State University to operate the NIDA Center for Genetic Studies. This single-award contract has a 5-year period of performance through March 2028. Under this IDC, Rutgers will receive, process, store and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research...
The Department of Homeland Security Science and Technology Directorate has awarded a single-award Basic Ordering Agreement (BOA) to Rutgers, The State University for a potential total value of $0.00. The BOA covers six thrust areas including the Coastal Hazards Center of Excellence and the Center of Excellence for Emerging and Zoonotic Infectious Diseases. Rutgers, a non-profit 1862 land grant educational institution, will provide a range of research and development services through this BOA....
The National Institute on Drug Abuse (NIDA) has awarded an Indefinite Delivery Contract (IDC) to Infinity Biologix LLC, doing business as Sampled Division, to maintain and expand the NIDA Center for Genetic Studies (NCGS) over a 5-year period. The $15,000,000 contract aims to create a repository to receive, process, and store de-identified biospecimens and associated clinical and phenotypic data from NIDA-funded genetic addiction research, and to make these resources widely available to...
The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a single-award Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, for the preparation and distribution of research drug products. The $19,975,000 contract has a period of performance from March 20, 2025 to March 19, 2029, with a final completion date of March 19, 2026 for the initial $1,497,865 delivery order. RTI International, an experienced...
The Department of Veterans Affairs (VA) awarded an indefinite delivery contract (IDC) to Rutgers, The State University of New Jersey, doing business as Rbhs-New Jersey Medical School, a non-profit 1862 land grant college. The $381,972 IDC supports collaborative biplanar fluoroscopy research to study bone and skin movement in individuals with transtibial amputations. Under this IDC, the VA has issued three delivery orders to Rutgers worth a total of $291,602 to date. The work is performed at...
The National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, has awarded an Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, to provide synthesis and distribution services for drugs of abuse and related compounds. The contract has a ceiling value of $14,004,330 and a period of performance from June 9, 2022 to June 8, 2027. This contract supports NIDA's mission of conducting...
The National Institutes of Health National Institute on Drug Abuse (NIDA) awarded an indefinite delivery contract to the nonprofit Research Triangle Institute (RTI) International for the Preparation and Distribution of Research Drug Products. The contract, valued at up to $19,975,000, has a period of performance from September 20, 2019 to September 19, 2024 and does not utilize any set-aside designations. Under this contract, RTI provides a variety of services to NIDA including the...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), has awarded an Indefinite Delivery Contract (IDC) to Actuated Medical, Inc., doing business as Piezo Resonance Innovations Inc. The $35 million, single-award IDC runs through September 2028 and is for research and development services related to biocompatibility testing, animal studies, and sterilization testing in support of NIDA's Blueprint MedTech (BPMT) Initiative. This work involves...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded an indefinite delivery/indefinite quantity (IDIQ) contract to The Emmes Company LLC, a for-profit limited liability company, to serve as the NIDA Data, Statistics, and Clinical Trial Support Center. Under this single-award IDIQ contract valued up to $31.2 million over a five-year period from September 2022 to September 2027, The...
The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) awarded an Indefinite Delivery Contract (IDC) to The Bizzell Group LLC, a U.S. Small Business Administration (SBA) certified HUBZone and minority-owned firm. The contract, valued at up to $1,000,000, provides logistics, communications, and clinical study auxiliary support services to NIDA's Division of Therapeutics and Medical Consequences from May 2021 through April 2026. To...
The National Institute on Drug Abuse awarded Rutgers, The State University a single-award Indefinite Delivery Contract to establish and operate the NIDA Center for Genetic Studies. The contract has a potential value of $19.7 million over a five-year base period from September 2018 to September 2022. Rutgers has received multiple firm fixed price task orders against the contract to provide research services in support of the Center, including receiving, processing, storing, and distributing de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts. Task orders have ranged in value from $350,819 to $2.5 million for periods of performance from March 2019 to September 2022. Services are performed at Rutgers' location in New Brunswick, New Jersey.
The original solicitation sought proposals to furnish necessary services to support the NIDA Center for Genetic Studies, including receiving, processing, storing, and distributing de-identified biospecimens and data from addiction genetics research grants. Mandatory requirements included the ability to safely process and store over 90,000 biospecimen samples, obtain a Certificate of Confidentiality, and agree to distribute high-quality data, documentation, and materials to qualified investigators. The contract was awarded on a single-award basis to leverage Rutgers' expertise in genetic research and assist NIDA's mission to advance the understanding of genetics' role in substance use disorders.